TackSHS Final Conference at the European Parliament (Brussels)

TackSHS_185_preview

Tackling tobacco-related chronic diseases in Europe: Novel data from the Horizon 2020 TackSHS project reveals the results of exposure to secondhand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes on the respiratory health of European population, the burden of associated mortality and morbidity, and economic consequences for national and European welfare.

These important findings were presented for discussion to a wide audience of about 100 European stakeholders during the Project Final Conference at the European Parliament on 8 October, kindly hosted by MEP Cristian-Silviu Buşoi and MEP Rosa Esteràs Ferragut.

TackSHS_043_preview

After a welcoming word of MEP Bușoi, the Conference was launched with the presentations of Mrs. Thea Emmerling (Head of Unit, the Cross-border health care and tobacco control, DG SANTE, European Commission) and Dr. Francisco Lozano (President, European Network for Smoking and Tobacco Prevention) on the state of tobacco control in Europe and related policy priorities. The opening session was followed by a comprehensive project overview delivered by its coordinator, Prof. Esteve Fernández (Director, Tobacco Control Unit at the Catalan Institute of Oncology).

TackSHS_069_previewTackSHS_091_preview

During an interactive debate moderated by Dr. Armando Peruga (Former Programme Manager of WHO’s Tobacco Free Initiative), participating researchers shared worrying numbers concerning: 1) secondhand tobacco smoke exposure, electronic cigarette use and passive exposure to their aerosols; and 2) burden of SHS exposure.

Daily exposure to SHS among non-smokers is highly prevalent in most European countries (31% overall, ranging between 24% in Ireland and 68% in Greece), especially in indoor and outdoor settings of hospitality venues, workplaces, and homes and cars. Smoking occurs and SHS is present in almost all outdoor terraces of bars and restaurants across Europe, even in countries with legislation in these settings. Moreover, smoking occurs and SHS is present in most playgrounds and entrances to schools across Europe, especially in deprived neighborhoods and countries with lower tobacco control climate.

Across Europe, three out of five smokers allow smoking in their homes, with very high levels of SHS exposure detected, potentially affecting children and other bystanders. In addition, SHS levels in cars of smokers are very high, with nicotine concentrations exceeding those observed in smokers’ homes.

The studies led to a conclusion that the burden attributable to SHS exposure is still substantial in the EU, mainly due to SHS exposure at home. Only in 2017, among children aged 0-14 years, exposure to SHS at home was associated with 344 deaths (1.5% of total deaths in children) and 37,000 disability-adjusted life years (0.75% of total DALYs), whereas in non-smoking adults it was responsible of 30,000 deaths (0.6% of total deaths) and 712,000 DALYs (0.5% of total DALYs).

Furthermore, the annual cost of lost DALYs due to exposure to SHS is 356 million (of Purchasing Power Parity Adjusted euro of year 2017) on average in the EU 28 Member States. With regards to electronic cigarette use and exposure to their aerosols, the analysis demonstrated that the prevalence of use is low and diverse in Europe, more frequent among youth and usually concurrent with traditional cigarette smoking. The tests confirmed that electronic cigarette use impairs air quality with particulate matter, nicotine, volatile organic compounds, among others; while individuals exposed to electronic cigarettes aerosol showed immediate alterations of their lung function (respiratory mechanics and exhaled biomarkers) and experienced symptoms of eye, nose and throat irritation.

In the end, the outcomes of TackSHS project aim to serve as a solid base for addressing health inequalities caused by the use of conventional tobacco and electronic cigarettes. TackSHS results provide scientific evidence much-needed to facilitate urgent policy changes such as closing legislation gaps in regulation of novel and emerging products, while improving and strengthening comprehensive smoking bans in every EU Member State.